Full-Time
Data Engineer
Data Products
Posted on 9/4/2025
AcuityMD
201-500 employees
SaaS platform optimizing MedTech commercial strategy
Compensation Overview
$120k - $165k/yr
No H1B Sponsorship
Remote in USA + 1 more
More locations: Boston, MA, USA
Remote
Candidates must have an eligible work permit in the USA or Canada.
 Data & Analytics (1) |
|---|
- 2+ years of experience working in a data or analytical role building data or doing quantitative analysis of data
- Excellent problem-solving skills and ability to apply math/statistics to data problems
- Ability to communicate business concepts, technical requirements, recommendations and code clearly and concisely
- Experience building data transforms and pipelines using a programming language such as Python
- Demonstrated ability to explore, transform, and analyze data in any type of relational database using SQL
- Model new data and improve existing data products with quantitative rigor that solve customer problems and ensure correctness and interpretability
- Transform and integrate raw data from multiple sources into usable, documented and high quality data and intelligence products by applying data modeling and statistical techniques
- Work directly with product managers and cross-functional stakeholders to design solutions, validation frameworks and statistical benchmarks
- Document and communicate technical and quantitative concepts, schemas, and data product usage guidelines for internal stakeholders
- Develop and maintain batch data pipelines using Python and SQL with automated quality check
- Familiarity across our data stack - BigQuery, Google Cloud Storage, dbt & Dagster
- Familiarity with healthcare billing/data
- Familiarity with dimensional modeling
- Familiarity with incorporating LLM models into development workflows
AcuityMD offers a SaaS platform for the MedTech industry to identify target markets, surface top opportunities, and grow revenue across the product lifecycle. It turns large healthcare data into intuitive workflows that align sales and marketing with the overall commercial process. The platform includes market research, growth opportunity spotting, and sales strategy optimization available by subscription. Its goal is to improve market focus and accelerate revenue growth, helping medical devices reach patients faster.
Company Size
201-500
Company Stage
Series C
Total Funding
$163M
Headquarters
Boston, Massachusetts
Founded
2018
Simplify's Take
What believers are saying
- Global medical devices market grows $623B to $1T by 2035, expanding AcuityMD's addressable customer base.
- 1,200+ FDA-authorized AI devices intensify competition, driving demand for AcuityMD's data-driven prioritization platform.
- Salesforce integration and voice assistant adoption accelerate workflow efficiency and reduce manual data entry burden.
What critics are saying
- Definitive Healthcare captures market share with broader healthcare intelligence beyond MedTech silos within 24 months.
- CMS enforces stricter HIPAA de-identification rules Q2 2026, crippling AcuityMD's 330M-patient claims dataset.
- Epic-OpenAI partnership embeds procedure forecasting directly in EHRs, bypassing standalone AcuityMD platform entirely.
What makes AcuityMD unique
- Purpose-built MedTech ontology maps physicians, procedures, reimbursement rules, and product relationships uniquely.
- Proprietary dataset from 330+ million patients via CMS and claims aggregators enables precise targeting.
- Agentic AI delivers contextual next-best actions embedded directly in sales rep workflows and CRM systems.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Flexible Work Hours
Unlimited Paid Time Off
Paid Health, Dental, and Vision Plans
Home Office Stipend
Learning Budget
Parental Leave
Company Equity
Optional Team Retreats
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 1%2 year growth
↑ 4%AcuityMD has launched AcuityMD for Salesforce on Salesforce AppExchange, enabling medical technology companies to integrate its AI-powered platform directly with Salesforce. The integration helps commercial teams identify sales opportunities, prioritise targets and streamline workflows by syncing data between both systems. The platform combines healthcare data with AI insights to eliminate manual updates and keep information consistent across systems. Sales representatives can work within existing Salesforce processes whilst gaining clearer visibility into high-value opportunities. AcuityMD serves over 400 MedTech companies, including eight of the top 10, and was named to Forbes' 2025 "Next Billion-Dollar Startups" list. The company provides targeting, account and opportunity data to help teams from pre-commercial to enterprise accelerate medical technology adoption.
Electromedical Products International (EPI) expands access of unique medical technology to veterans experiencing anxiety, insomnia, pain. In recognition of Veterans Day, AcuityMD announces its partnership with Electromedical Products International (EPI) to drive access to Alpha-Stim(R), a non-invasive, FDA-cleared device that uses cranial electrotherapy stimulation (CES) and microcurrent electrical therapy (MET) to treat anxiety, insomnia, and pain for U.S. military veterans. While available to all patients diagnosed with these conditions, Alpha-Stim is uniquely appealing to veterans who may have concerns with long-term prescription drug treatments. Through its partnership with AcuityMD, EPI has expanded its use to community care providers and has achieved major gains in both pipeline growth and technology adoption. Between 2019 and 2023, over half a million active-duty service members were diagnosed with at least one mental health disorder - a 40% rise over five years. Further, nearly 35 of every 100,000 veterans commit suicide, a rate that is rising significantly faster than for non-veterans. Now, veterans like Dakota Meyer, a former U.S. Marine Sergeant and a Medal of Honor recipient, are finally getting relief from chronic mental health challenges. "Even some of my worst days in Afghanistan were easier than my regular days when I returned home," said Meyer. "For seven years, I tried almost everything, but nothing worked. I also did not like the disruptive effect of drugs on my daily life. Finally, I found Alpha-Stim and it melted the anxiety away." U.S. Army Veteran and EPI Customer Care Manager Liz Mataraza understands. "Not all wounds are visible. Many veterans have told me that Alpha-Stim has changed their lives. When clinicians learn about it, they want to prescribe it. Many are cautious about prescribing medications that may have side effects or dependency potential," she explained. "Alpha-Stim offers clinicians a safe, effective alternative and helps patients feel calmer and more in control, but we needed a more data-driven approach to reach VA clinics, hospitals, and providers." Using AcuityMD's AI platform, EPI gained visibility into VA and community care data to identify high-need clinics. With these insights, the company's field representatives now target clinicians most likely to treat veterans struggling with anxiety, insomnia and pain. EPI also uses AcuityMD payer data to identify community clinics, private practices, and relevant specialists, conducting procedures covered by the VA in third-party facilities, helping to extend access to many more veterans. "We have witnessed incredible upside in potential and growth since implementing AcuityMD," said Brian Burke, President of EPI. "We now have a bigger market and greater penetration, plus significant improvement in sales productivity. For example, reps may now visit one clinic but actually meet with five relevant clinicians that they might not have known before AcuityMD. It is a sales multiplier." Burke concluded, "AcuityMD has become an integral part of our strategic decision making. It provides valuable insights into market trends, physician prescribing patterns, and patient needs that help us continuously refine our commercial strategy. Our mission is to bring Alpha-Stim to every patient in need, especially veterans, and AcuityMD plays an important role in advancing that mission." To learn more about AcuityMD's AI platform for MedTech, visit acuitymd.com. About AcuityMD AcuityMD is the AI platform for MedTech, used by more than 400 companies, including eight of the top 10. Commercial leaders rely on AcuityMD to identify target markets, surface top opportunities, and grow their business. By combining real-world healthcare data with AI-powered insights, AcuityMD enables companies from pre-commercial to enterprise to understand where and how to sell faster to accelerate the adoption of medical technology. AcuityMD was named to Forbes' 2025 "Next Billion-Dollar Startups" list - an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation. For more information visit AcuityMD.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20251111139680/en/ For seven years, I tried almost everything, but nothing worked. I also did not like the disruptive effect of drugs on my daily life. Finally, I found Alpha-Stim and it melted the anxiety away.
Preceptis Medical selects AcuityMD for expansion of breakthrough in-office pediatric ear tube device. AcuityMD's data and insights drive commercial growth of important new option to families seeking alternatives for routine ear tube placement in millions of children BOSTON-(BUSINESS WIRE)-In recognition of Children's Health Month, AcuityMD, the AI platform for MedTech, announced that Preceptis Medical has selected its platform to support an expanded market launch of the Hummingbird(R) Tympanostomy Tube System (TTS). TTS offers a unique approach for pediatric ear tube placement in the office without the need for the operating room or general anesthesia. Preceptis Medical, a medical device company focused on office-based options for pediatric patients, chose AcuityMD for its deep industry expertise, comprehensive market data, and AI-driven insights to guide commercial decision making. AcuityMD will help us engage with the right surgeons, and create greater awareness amongst payers, pediatricians, and parents about our unique solution. Share "We are an emerging company focused on growth through expanding patient access, and needed a powerful technology platform that would allow our team to work smarter, faster, and make informed decisions," said David Carey, CEO of Preceptis Medical. "Our early market release demonstrated strong adoption and the need to further expand our footprint in the market. The platform offers insights on the right physicians to engage, how to hire strategically, set up smarter sales territories, and make better decisions at every step." Approximately one million children annually will undergo ear tube procedures in the U.S., and by age three, one out of every 15 children will have tubes. Patients usually undergo the procedure in an operating room, which can be costly, have more risk, and be restrictive for many families. Further, both parents and pediatricians want to avoid exposing children to general anesthesia when possible, making the Hummingbird office procedure a simpler and preferred option. According to Shelagh A. Cofer, M.D., a pediatric otolaryngologist and surgeon at Mayo Clinic in Minnesota who participated in a clinical trial with Preceptis Medical, the Hummingbird TTS is a 'single-pass' tool because it is designed to reduce steps and enable ear tube cases to be performed quickly in the office versus the operating room. "It's a revolutionary step forward for our field," said Dr. Cofer. Carey concluded, "AcuityMD is the cornerstone of our Hummingbird Catalyst program, where we partner with customers to increase Hummingbird awareness and access in the community. AcuityMD will help us engage with the right surgeons, and create greater awareness amongst payers, pediatricians, and parents about our unique solution." To learn more about how AcuityMD enables Preceptis Medical and other MedTech companies to expand access to their breakthrough devices, visit www.acuitymd.com. About AcuityMD AcuityMD is the AI platform for MedTech and trusted by more than 400 MedTech companies - including six of the top 10. Commercial leaders use AcuityMD to identify target markets, surface top opportunities, and grow their business. By combining real-world healthcare data with AI-powered insights, AcuityMD enables companies from pre-commercial to enterprise to understand where and how to sell faster to accelerate the adoption of medical technology. AcuityMD was named to Forbes' 2025 "Next Billion-Dollar Startups" list - an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation. Media Contact: Lisa Barbadora, Barbadora INK for AcuityMD +1 (610) 420-3413 [email protected] More News From AcuityMD BOSTON-( BUSINESS WIRE )-AcuityMD, the AI platform for MedTech, announced today at its annual Flywheel event for commercial leaders a major expansion of its platform with new AI tools to give medical device companies visibility into forecasted sales performance, business risks, and next-best actions to reach their goals. AcuityMD is modernizing how MedTech companies go to market by applying AI to improve efficiency and effectiveness - ultimately accelerating the delivery of life-changing medica... BOSTON-( BUSINESS WIRE )-AcuityMD, the MedTech Intelligence Platform, has been named to Forbes' 2025 "Next Billion-Dollar Startups" list - an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation. The list has a strong track record: more than 100 startups named in the past 10 years have since become unicorns. This recognition highlights AcuityMD's rapid growth and innovation since its inception in 2019. Over the past year, the company signed i... BOSTON-( BUSINESS WIRE )-AcuityMD, the MedTech Intelligence Platform, today announced a new solution that will help MedTech companies and healthcare providers (HCPs) deliver new treatment options to more patients. Referral Pathways in AcuityMD Care Journeys provides comprehensive patient referral data so MedTech commercial teams can easily identify the physicians who can most benefit from their products and bring innovations to more patients. AcuityMD Care Journeys, launched in October 2024, wa...
AcuityMD expands AI platform to boost medtech sales performance. NEWS RELEASE: AcuityMD launches MedTech AI tools to accelerate commercial growth. BOSTON - AcuityMD, the AI platform for MedTech, announced today at its annual Flywheel event for commercial leaders a major expansion of its platform with new AI tools to give medical device companies visibility into forecasted sales performance, business risks, and next-best actions to reach their goals. AcuityMD is modernizing how MedTech companies go to market by applying AI to improve efficiency and effectiveness - ultimately accelerating the delivery of life-changing medical innovations to patients. In today's competitive market, MedTech commercial teams face constant pressure to hit sales targets, but fragmented tools and incomplete data make it hard to forecast accurately and prioritize the right opportunities. AcuityMD solves this by delivering reliable forecasts and AI-driven action plans that help leaders focus resources, guide reps to the best opportunities, and accelerate revenue growth. Built on AcuityMD's foundation of real-world market data and advanced targeting technology, the new AI enhancements add a powerful layer of insights plus guided execution that continuously adapt and improve over time. With AcuityMD, MedTech companies can now: * Hit quotas faster with generative next-best actions - sales representatives are automatically guided to the highest-value opportunities with the strongest likelihood of success. The AI recommendation engine continuously learns from interactions to deliver smarter, more personalized guidance over time. * Plan with precision with MedTech-specific forecasting - leaders can make better strategic decisions by combining sales data, run-rate business projections, and weighted pipeline data into a single, reliable forecast that is purpose-built for MedTech. * Unlock field intelligence with an AI voice assistant - convert sales representatives' observations into structured insights, cutting manual data entry and ensuring timely and accurate field information. "Most forecasting tools stop at projecting outcomes," said Brian Collins, Chief Product Officer at AcuityMD. "Our platform goes further by showing teams how to achieve outcomes. Together with our customers, we're applying AI to bring clarity, focus, and faster adoption of medical technology." Corza Biosurgery Area Sales Director Pat O'Brien added, "Our sales data was spread across multiple platforms, which created a significant administrative burden and made it difficult for leadership to track performance to quota." Fellow Area Sales Director Kara Dillon concluded, "AcuityMD has given us the ability to instantly assess sales performance, support our reps where needed, and create more accurate quotas based on real data." Both Pat O'Brien and Kara Dillon are speaking at AcuityMD's Flywheel 2025 in Chicago today. Learn more at www.acuitymd.com or schedule a demo here. About AcuityMD. AcuityMD is the AI platform for MedTech and trusted by more than 400 MedTech companies - including six of the top 10. Commercial leaders use AcuityMD to identify target markets, surface top opportunities, and grow their business. By combining real-world market data with AI-powered insights, AcuityMD enables companies from pre-commercial to enterprise to understand where and how to sell faster to accelerate the adoption of medical technology. AcuityMD was named to Forbes' 2025 "Next Billion-Dollar Startups" list - an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation. Learn more at www.acuitymd.com. The opinions expressed in this news release are the author's only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.
AcuityMD was also recently named to Newsweek's "America's Greatest Startup Workplaces 2025."